Clinical Trial Update: Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Ga-67 citrate and Indium-111 DTPA for imaging CSF flow in central nervous system tumors; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Central Nervous System Tumors

Drugs mentioned

• Gallium-67 citrate (Gallium-67 citrate)
• Indium-111 DTPA (Indium-111 DTPA)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Central Nervous System Tumors, Brain Tumors | Phase 1 | Status: TERMINATED